HomeCLINICAL TRIALS, STUDIES, REGISTRIES, DATA

CLINICAL TRIALS, STUDIES, REGISTRIES, DATA

Medtronic Reports 1st Implant In Study to Evaluate Investigational, Closed Loop Neurostimulator for the RX of Chronic Pain

Prospective study will evaluate the long-term performance of the closed-loop algorithm and overall patient experience with Medtronic’s next-generation, rechargeable spinal cord stimulation device.

Filterlex Medical Successfully Completes First-In-Human Study for CAPTIS® Full-Body Embolic Protection Device

The FIH study was designed to demonstrate the safety and feasibility of the CAPTIS device in patients undergoing notes Filterlex Medical.

Magneto Thrombectomy Solutions Announces Successful First-in-Human Results for Treatment of Pulmonary Embolism

The eTrieve™ catheter for removing blood clots, based on electric fields, met safety and feasibility endpoints reports Magneto Thrombectomy Solutions.

Rockley Photonics Reports Results of Preliminary Human Study Measuring Hydration and Introduces a Novel Hydration Index

Rockley Photonics has also created a new hydration index for reporting relative hydration levels with the potential to simplify the complex process of measuring personal hydration.

Cybin and Kernel Announce Results from Kernel Flow® Piloting of Feasibility Study Measuring Ketamine’s Effects on the Brain

Preliminary data confirm Flow's ability to successfully measure neuro-effect of ketamine over 10 days reports Kernel.

ONWARD Medical Announces 1st Patient Enrollment in HemON Study and First-in-Human Use of its ARCIM Implantable Neurostimulator

ARCIM implantable pulse generator is designed to stimulate the spinal cord to restore movement and autonomic function for people with spinal cord injury and other conditions that affect mobility notes ONWARD Medical.

TecTraum Announces Completion of Multisite Clinical Trial Using pro2cool® Device for the Treatment of Concussions

The novel system is being studied for its potential to enhance and accelerate recovery reports TecTraum.

U.S. STAR-D Pivotal Trial Evaluating the DrugSorb™ – 1st Patient Enrolled

STAR-D pivotal trial is being performed under the auspices of an FDA Breakthrough Device Designation and is expected to enroll up to 120 patients across 30 sites in the United States.

Vectorious Medical Technologies Begins the VECTOR-HF II Study of its Implantable In-Heart Sensor for Left Atrial Pressure-Guided Patient Self-Management of Heart Failure

Vectorious Medical Technologies advises for the first time, heart failure patients can have full visibility of their hearts’ LA pressure and self-adjust their medication to stop further deterioration and avoid hospitalizations.